Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting

View ORCID ProfileLaith J. Abu Raddad, View ORCID ProfileHiam Chemaitelly, View ORCID ProfileJoel A. Malek, Ayeda A. Ahmed, Yasmin A. Mohamoud, Shameem Younuskunju, View ORCID ProfileHoussein H. Ayoub, View ORCID ProfileZaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, View ORCID ProfileHanan F. Abdul Rahim, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Sheikh Mohammad Al Thani, Roberto Bertollini
doi: https://doi.org/10.1101/2020.08.24.20179457
Laith J. Abu Raddad
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laith J. Abu Raddad
  • For correspondence: lja2002@qatar-med.cornell.edu
Hiam Chemaitelly
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hiam Chemaitelly
Joel A. Malek
4Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
5Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joel A. Malek
Ayeda A. Ahmed
4Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasmin A. Mohamoud
4Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shameem Younuskunju
4Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Houssein H. Ayoub
5Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Houssein H. Ayoub
Zaina Al Kanaani
6Hamad Medical Corporation, Doha, Qatar
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zaina Al Kanaani
Abdullatif Al Khal
6Hamad Medical Corporation, Doha, Qatar
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Einas Al Kuwari
6Hamad Medical Corporation, Doha, Qatar
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adeel A. Butt
6Hamad Medical Corporation, Doha, Qatar
MBBS MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Coyle
6Hamad Medical Corporation, Doha, Qatar
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Jeremijenko
6Hamad Medical Corporation, Doha, Qatar
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anvar Hassan Kaleeckal
6Hamad Medical Corporation, Doha, Qatar
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Nizar Latif
6Hamad Medical Corporation, Doha, Qatar
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riyazuddin Mohammad Shaik
6Hamad Medical Corporation, Doha, Qatar
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanan F. Abdul Rahim
7College of Health Sciences, QU Health, Qatar University, Doha, Qatar
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hanan F. Abdul Rahim
Hadi M. Yassine
8Biomedical Research Center, Qatar University, Doha, Qatar
9Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed G. Al Kuwari
10Primary Health Care Corporation, Doha, Qatar
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamad Eid Al Romaihi
11Ministry of Public Health, Doha, Qatar
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheikh Mohammad Al Thani
11Ministry of Public Health, Doha, Qatar
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Bertollini
11Ministry of Public Health, Doha, Qatar
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is debated. We assessed risk and incidence rate of documented SARS-CoV-2 reinfection in a large cohort of laboratory-confirmed cases in Qatar.

Methods All SARS-CoV-2 laboratory-confirmed cases with at least one PCR positive swab that is ≥45 days after a first-positive swab were individually investigated for evidence of reinfection, and classified as showing strong, good, some, or weak/no evidence for reinfection. Viral genome sequencing of the paired first-positive and reinfection viral specimens was conducted to confirm reinfection. Risk and incidence rate of reinfection were estimated.

Results Out of 133,266 laboratory-confirmed SARS-CoV-2 cases, 243 persons (0.18%) had at least one subsequent positive swab ≥45 days after the first-positive swab. Of these, 54 cases (22.2%) had strong or good evidence for reinfection. Median time between first and reinfection swab was 64.5 days (range: 45-129). Twenty-three of the 54 cases (42.6%) were diagnosed at a health facility suggesting presence of symptoms, while 31 (57.4%) were identified incidentally through random testing campaigns/surveys or contact tracing. Only one person was hospitalized at time of reinfection, but still with mild infection. No deaths were recorded. Viral genome sequencing confirmed four out of 12 cases with available genetic evidence. Risk of reinfection was estimated at 0.01% (95% CI: 0.01-0.02%) and incidence rate of reinfection was estimated at 0.36 (95% CI: 0.28-0.47) per 10,000 person-weeks.

Conclusions SARS-CoV-2 reinfection can occur but is a rare phenomenon suggestive of a strong protective immunity against reinfection that lasts for at least a few months post primary infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors are grateful for support provided by the Ministry of Public Health, Hamad Medical Corporation, and the Biomedical Research Program, the Biostatistics, Epidemiology, and Biomathematics Research Core, and the Genomics Core at Weill Cornell Medicine-Qatar. The statements made herein are solely the responsibility of the authors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Studies were approved by Hamad Medical Corporation and Weill Cornell Medicine-Qatar Institutional Review Boards.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Relevant data are available within the manuscript and appendix.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 28, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
Laith J. Abu Raddad, Hiam Chemaitelly, Joel A. Malek, Ayeda A. Ahmed, Yasmin A. Mohamoud, Shameem Younuskunju, Houssein H. Ayoub, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Sheikh Mohammad Al Thani, Roberto Bertollini
medRxiv 2020.08.24.20179457; doi: https://doi.org/10.1101/2020.08.24.20179457
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
Laith J. Abu Raddad, Hiam Chemaitelly, Joel A. Malek, Ayeda A. Ahmed, Yasmin A. Mohamoud, Shameem Younuskunju, Houssein H. Ayoub, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Sheikh Mohammad Al Thani, Roberto Bertollini
medRxiv 2020.08.24.20179457; doi: https://doi.org/10.1101/2020.08.24.20179457

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1746)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (651)
  • Epidemiology (10770)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2930)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (741)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12495)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (319)
  • Neurology (2778)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1451)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2626)
  • Public and Global Health (5336)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)